|
Business
The profit of protectionPublished 05/11/08
Last year, David Wright, president of Annapolis-based biodefense firm PharmAthene, flew into the Durham Tees Valley Airport to meet with senior officials from a United Kingdom company called Avecia.
Courtesy photo
After several trips and months of negotiation, Mr. Wright wooed Avecia to the table in a deal that allows PharmAthene to purchase the rights to develop the company's anthrax vaccines, now deep in the development stages.
Last month, PharmAthene closed on a $40 million deal with the United Kingdom company, building up its biodefense portfolio in the works since 2001. Now, the Annapolis company hopes Avecia's vaccines will help...
|
| #1 - Anti-illegal-immigration group draws controversy (46 comments) |
| #2 - Severna Park forfeits county title (42 comments) |
| #3 - Man: Police forced him to delete photos (13 comments) |
| #4 - Cohen wins race for Annapolis mayor (12 comments) |
| #5 - Suspect in assault top military wrestler (11 comments) |
If you encounter other problems, please email ewiffin@capitalgazette.com and include your name, username, and any errors or messages that are displayed. The more information you can provide, the better able we will be to assist you.
In order to post or vote on a comment, you must be signed in with a hometownannapolis account.
Take a look at a summary of Commenting Guidelines.
If you encounter other problems, please email ewiffin@capitalgazette.com and include your name, username, and any errors or messages that are displayed. The more information you can provide, the better able we will be to assist you.